Carver Kyle

Insider profile

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Carver Kyle's trades of Evommune Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
90.36
Quantity 13,679 -45.2%
Value US$2,824,750
Transaction date
Planned sale
Price
64.45
Quantity 64,476 +24.0%
Value US$23,244
Transaction date
Proposed sale
Price
497.91
Quantity 27,819
Value US$425,291
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-10 2026-07-08 B Purchase
13,679 -45.2%
90.36
US$2,824,750
13,679 -45.2% 90.36 US$2,824,750
2026-06-01 2026-05-28 PlS Planned sale
64,476 +24.0%
64.45
US$23,244
64,476 +24.0% 64.45 US$23,244
2026-05-28 2026-05-28 PrS Proposed sale
27,819
497.91
US$425,291
27,819 497.91 US$425,291